Coloring outside the lines of traditional PD therapies

Posted on by Phil Franchina

ย New Program Offers Creative Outlet, Improves PD Symptoms ย An innovative new...see more program offers a host of benefits for people with Parkinsonโ€™s who have challenges in visual perception and spatial relations, affecting their ability to move through the world. Most current PD treatment regimens donโ€™t focus on this […]

Read More

Creating Connections

Posted on by Phil Franchina

  Beyond the Doctorโ€™s Visit: Taking Parkinsonโ€™s Care to the Next Level โ€œGame changing.โ€ Thatโ€™s how Robin...see more Kornhaber, Senior Vice President, National Programs and Partnerships at the American Parkinson Disease Association (APDA), describes APDA Information and Referral (I&R) Centers. APDA I&R Centers are at medical institutions across the country where APDA supports either […]

Read More

Taking Parkinsonโ€™s education to the farmers market: educating under-served communities

Posted on by Phil Franchina

Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian...see more Medical Center in New York City, attended APDAโ€™s Diversity in Parkinsonโ€™s Disease (PD) Research Conference in May and was inspired. Dr. Nwabuobi ย had just spent the day learning about health care disparities in PD care, low […]

Read More

THE AMERICAN PARKINSON DISEASE ASSOCIATION AWARDS FRESH CROP OF RESEARCH GRANTS & NEW DIVERSITY-FOCUSED RESEARCH INITIATIVE

Posted on by Phil Franchina

The American Parkinson Disease Association Awards Fresh Crop of Research Grants & New Diversity-Focused Research Initiative From T cells...see more to genetics, $1.7 million in innovative research to be funded for 2019 โ€“ 2020 year NEW YORK, NY โ€“ September 5, 2019 โ€“ The American Parkinson Disease Association (APDA) has just awarded $1.7 million to support […]

Read More

New medication, Istradefylline, gets approved for Parkinsonโ€™s disease

Posted on by Phil Franchina

On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval...see more for Istradefylline, a new medication for Parkinsonโ€™s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA […]

Read More